The global Microneedle-based Drug Delivery System market size was valued at USD 3 million in 2023 and is forecast to a readjusted size of USD 121.7 million by 2030 with a CAGR of 71.8% during review period.
Microneedle drug delivery systems usually include Hollow Microneedle Technology microneedle and Dissolving Microneedles Technology microneedle technology, offer patient-friendly delivery solutions for vaccines or difficult-to-deliver biologics for particularly needle-phobic patients.
In this report, we mainly study the forecast market due to there is no product on the market, most product on the research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The report includes an overview of the development of the Microneedle-based Drug Delivery System industry chain, the market status of Drug Delivery (Hollow Microneedle Technology, Solid Microneedle Technology), Vaccine Delivery (Hollow Microneedle Technology, Solid Microneedle Technology), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Microneedle-based Drug Delivery System.
Regionally, the report analyzes the Microneedle-based Drug Delivery System markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Microneedle-based Drug Delivery System market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Microneedle-based Drug Delivery System market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Microneedle-based Drug Delivery System industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Hollow Microneedle Technology, Solid Microneedle Technology).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Microneedle-based Drug Delivery System market.
Regional Analysis: The report involves examining the Microneedle-based Drug Delivery System market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Microneedle-based Drug Delivery System market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Microneedle-based Drug Delivery System:
Company Analysis: Report covers individual Microneedle-based Drug Delivery System players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Microneedle-based Drug Delivery System This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Drug Delivery, Vaccine Delivery).
Technology Analysis: Report covers specific technologies relevant to Microneedle-based Drug Delivery System. It assesses the current state, advancements, and potential future developments in Microneedle-based Drug Delivery System areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Microneedle-based Drug Delivery System market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Microneedle-based Drug Delivery System market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Hollow Microneedle Technology
Solid Microneedle Technology
Dissolving Microneedles Technology
Market segment by Application
Drug Delivery
Vaccine Delivery
Market segment by players, this report covers
KINDEVA
Zosano Pharma
Becton-Dickinson(BD)Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect, Inc
Vaxxas
Lohmann Therapie-Systeme AG
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Microneedle-based Drug Delivery System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Microneedle-based Drug Delivery System, with revenue, gross margin and global market share of Microneedle-based Drug Delivery System from 2019 to 2024.
Chapter 3, the Microneedle-based Drug Delivery System competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Microneedle-based Drug Delivery System market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Microneedle-based Drug Delivery System.
Chapter 13, to describe Microneedle-based Drug Delivery System research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Microneedle-based Drug Delivery System
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Microneedle-based Drug Delivery System by Type
1.3.1 Overview: Global Microneedle-based Drug Delivery System Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Microneedle-based Drug Delivery System Consumption Value Market Share by Type in 2023
1.3.3 Hollow Microneedle Technology
1.3.4 Solid Microneedle Technology
1.3.5 Dissolving Microneedles Technology
1.4 Global Microneedle-based Drug Delivery System Market by Application
1.4.1 Overview: Global Microneedle-based Drug Delivery System Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Drug Delivery
1.4.3 Vaccine Delivery
1.5 Global Microneedle-based Drug Delivery System Market Size & Forecast
1.6 Global Microneedle-based Drug Delivery System Market Size and Forecast by Region
1.6.1 Global Microneedle-based Drug Delivery System Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Microneedle-based Drug Delivery System Market Size by Region, (2019-2030)
1.6.3 North America Microneedle-based Drug Delivery System Market Size and Prospect (2019-2030)
1.6.4 Europe Microneedle-based Drug Delivery System Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Microneedle-based Drug Delivery System Market Size and Prospect (2019-2030)
1.6.6 South America Microneedle-based Drug Delivery System Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Microneedle-based Drug Delivery System Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 KINDEVA
2.1.1 KINDEVA Details
2.1.2 KINDEVA Major Business
2.1.3 KINDEVA Microneedle-based Drug Delivery System Product and Solutions
2.1.4 KINDEVA Microneedle-based Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 KINDEVA Recent Developments and Future Plans
2.2 Zosano Pharma
2.2.1 Zosano Pharma Details
2.2.2 Zosano Pharma Major Business
2.2.3 Zosano Pharma Microneedle-based Drug Delivery System Product and Solutions
2.2.4 Zosano Pharma Microneedle-based Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Zosano Pharma Recent Developments and Future Plans
2.3 Becton-Dickinson(BD)Technologies
2.3.1 Becton-Dickinson(BD)Technologies Details
2.3.2 Becton-Dickinson(BD)Technologies Major Business
2.3.3 Becton-Dickinson(BD)Technologies Microneedle-based Drug Delivery System Product and Solutions
2.3.4 Becton-Dickinson(BD)Technologies Microneedle-based Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Becton-Dickinson(BD)Technologies Recent Developments and Future Plans
2.4 Nanopass Technologies
2.4.1 Nanopass Technologies Details
2.4.2 Nanopass Technologies Major Business
2.4.3 Nanopass Technologies Microneedle-based Drug Delivery System Product and Solutions
2.4.4 Nanopass Technologies Microneedle-based Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Nanopass Technologies Recent Developments and Future Plans
2.5 Corium
2.5.1 Corium Details
2.5.2 Corium Major Business
2.5.3 Corium Microneedle-based Drug Delivery System Product and Solutions
2.5.4 Corium Microneedle-based Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Corium Recent Developments and Future Plans
2.6 Valeritas
2.6.1 Valeritas Details
2.6.2 Valeritas Major Business
2.6.3 Valeritas Microneedle-based Drug Delivery System Product and Solutions
2.6.4 Valeritas Microneedle-based Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Valeritas Recent Developments and Future Plans
2.7 Nitto
2.7.1 Nitto Details
2.7.2 Nitto Major Business
2.7.3 Nitto Microneedle-based Drug Delivery System Product and Solutions
2.7.4 Nitto Microneedle-based Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Nitto Recent Developments and Future Plans
2.8 Microdermics
2.8.1 Microdermics Details
2.8.2 Microdermics Major Business
2.8.3 Microdermics Microneedle-based Drug Delivery System Product and Solutions
2.8.4 Microdermics Microneedle-based Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Microdermics Recent Developments and Future Plans
2.9 TheraJect, Inc
2.9.1 TheraJect, Inc Details
2.9.2 TheraJect, Inc Major Business
2.9.3 TheraJect, Inc Microneedle-based Drug Delivery System Product and Solutions
2.9.4 TheraJect, Inc Microneedle-based Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 TheraJect, Inc Recent Developments and Future Plans
2.10 Vaxxas
2.10.1 Vaxxas Details
2.10.2 Vaxxas Major Business
2.10.3 Vaxxas Microneedle-based Drug Delivery System Product and Solutions
2.10.4 Vaxxas Microneedle-based Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Vaxxas Recent Developments and Future Plans
2.11 Lohmann Therapie-Systeme AG
2.11.1 Lohmann Therapie-Systeme AG Details
2.11.2 Lohmann Therapie-Systeme AG Major Business
2.11.3 Lohmann Therapie-Systeme AG Microneedle-based Drug Delivery System Product and Solutions
2.11.4 Lohmann Therapie-Systeme AG Microneedle-based Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Lohmann Therapie-Systeme AG Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Microneedle-based Drug Delivery System Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Microneedle-based Drug Delivery System by Company Revenue
3.2.2 Top 3 Microneedle-based Drug Delivery System Players Market Share in 2023
3.2.3 Top 6 Microneedle-based Drug Delivery System Players Market Share in 2023
3.3 Microneedle-based Drug Delivery System Market: Overall Company Footprint Analysis
3.3.1 Microneedle-based Drug Delivery System Market: Region Footprint
3.3.2 Microneedle-based Drug Delivery System Market: Company Product Type Footprint
3.3.3 Microneedle-based Drug Delivery System Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Microneedle-based Drug Delivery System Consumption Value and Market Share by Type (2019-2024)
4.2 Global Microneedle-based Drug Delivery System Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Microneedle-based Drug Delivery System Consumption Value Market Share by Application (2019-2024)
5.2 Global Microneedle-based Drug Delivery System Market Forecast by Application (2025-2030)
6 North America
6.1 North America Microneedle-based Drug Delivery System Consumption Value by Type (2019-2030)
6.2 North America Microneedle-based Drug Delivery System Consumption Value by Application (2019-2030)
6.3 North America Microneedle-based Drug Delivery System Market Size by Country
6.3.1 North America Microneedle-based Drug Delivery System Consumption Value by Country (2019-2030)
6.3.2 United States Microneedle-based Drug Delivery System Market Size and Forecast (2019-2030)
6.3.3 Canada Microneedle-based Drug Delivery System Market Size and Forecast (2019-2030)
6.3.4 Mexico Microneedle-based Drug Delivery System Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Microneedle-based Drug Delivery System Consumption Value by Type (2019-2030)
7.2 Europe Microneedle-based Drug Delivery System Consumption Value by Application (2019-2030)
7.3 Europe Microneedle-based Drug Delivery System Market Size by Country
7.3.1 Europe Microneedle-based Drug Delivery System Consumption Value by Country (2019-2030)
7.3.2 Germany Microneedle-based Drug Delivery System Market Size and Forecast (2019-2030)
7.3.3 France Microneedle-based Drug Delivery System Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Microneedle-based Drug Delivery System Market Size and Forecast (2019-2030)
7.3.5 Russia Microneedle-based Drug Delivery System Market Size and Forecast (2019-2030)
7.3.6 Italy Microneedle-based Drug Delivery System Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Microneedle-based Drug Delivery System Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Microneedle-based Drug Delivery System Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Microneedle-based Drug Delivery System Market Size by Region
8.3.1 Asia-Pacific Microneedle-based Drug Delivery System Consumption Value by Region (2019-2030)
8.3.2 China Microneedle-based Drug Delivery System Market Size and Forecast (2019-2030)
8.3.3 Japan Microneedle-based Drug Delivery System Market Size and Forecast (2019-2030)
8.3.4 South Korea Microneedle-based Drug Delivery System Market Size and Forecast (2019-2030)
8.3.5 India Microneedle-based Drug Delivery System Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Microneedle-based Drug Delivery System Market Size and Forecast (2019-2030)
8.3.7 Australia Microneedle-based Drug Delivery System Market Size and Forecast (2019-2030)
9 South America
9.1 South America Microneedle-based Drug Delivery System Consumption Value by Type (2019-2030)
9.2 South America Microneedle-based Drug Delivery System Consumption Value by Application (2019-2030)
9.3 South America Microneedle-based Drug Delivery System Market Size by Country
9.3.1 South America Microneedle-based Drug Delivery System Consumption Value by Country (2019-2030)
9.3.2 Brazil Microneedle-based Drug Delivery System Market Size and Forecast (2019-2030)
9.3.3 Argentina Microneedle-based Drug Delivery System Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Microneedle-based Drug Delivery System Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Microneedle-based Drug Delivery System Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Microneedle-based Drug Delivery System Market Size by Country
10.3.1 Middle East & Africa Microneedle-based Drug Delivery System Consumption Value by Country (2019-2030)
10.3.2 Turkey Microneedle-based Drug Delivery System Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Microneedle-based Drug Delivery System Market Size and Forecast (2019-2030)
10.3.4 UAE Microneedle-based Drug Delivery System Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Microneedle-based Drug Delivery System Market Drivers
11.2 Microneedle-based Drug Delivery System Market Restraints
11.3 Microneedle-based Drug Delivery System Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Microneedle-based Drug Delivery System Industry Chain
12.2 Microneedle-based Drug Delivery System Upstream Analysis
12.3 Microneedle-based Drug Delivery System Midstream Analysis
12.4 Microneedle-based Drug Delivery System Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
KINDEVA
Zosano Pharma
Becton-Dickinson(BD)Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect, Inc
Vaxxas
Lohmann Therapie-Systeme AG
听
听
*If Applicable.
